GUCY2C: at the intersection of obesity and cancer: Trends in Endocrinology & Metabolism
Phentermine/topiramate - Wikipedia
Obesity | NEJM
Diabetes & Metabolism Journal
![PDF] Understanding the Mechanism of Action and Clinical Implications of Anti-Obesity Drugs Recently Approved in Korea | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/386a1763c38c5fecc2b4e23127c05c784bec9fa3/3-Figure1-1.png "PDF] Understanding the Mechanism of Action and Clinical Implications of Anti-Obesity Drugs Recently Approved in Korea | Semantic Scholar")
PDF] Understanding the Mechanism of Action and Clinical Implications of Anti-Obesity Drugs Recently Approved in Korea | Semantic Scholar
Current Perspectives on Long-term Obesity Pharmacotherapy - Canadian Journal of Diabetes
Management of Obesity in Adults with CKD | American Society of Nephrology
Pharmacotherapy for the management of obesity - Metabolism - Clinical and Experimental
Antiobesity pharmacotherapy: new drugs and emerging targets. - Abstract - Europe PMC
Antiobesity Pharmacotherapy: New Drugs and Emerging Targets - Kim - 2014 - Clinical Pharmacology & Therapeutics - Wiley Online Library
Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand? - Abstract - Europe PMC
Cureus | Type II Renal Tubular Acidosis Secondary to Topiramate: A Review
Comorbidities and Complications - ppt download
Mechanisms underlying current and future anti-obesity drugs: Trends in Neurosciences
Cardiovascular Effects of the New Weight Loss Agents - ScienceDirect
Anti-obesity drug discovery: advances and challenges | Nature Reviews Drug Discovery
Anti-Obesity Therapy: from Rainbow Pills to Polyagonists | Pharmacological Reviews
Existing and Emerging Molecular Targets for the Pharmacotherapy of Obesity - Endotext - NCBI Bookshelf
Naltrexone/bupropion for obesity: An investigational combination pharmacotherapy for weight loss - ScienceDirect
Mechanism of action of long-term anti-obesity pharmacotherapies... | Download Scientific Diagram
topiramate
Qsymia Results : You are here
